Biomarkers for Cardiovascular Diseases Their Clinical Significances and Future Directions
S Fujii, A Ito, Y Watanabe - Annals of Nuclear Cardiology, 2016 - jstage.jst.go.jp
Biomarkers are used for evaluation of the pathophysiological state, risk stratification,
diagnostic tools, staging of a disease and responsiveness to treatment. Representative …
diagnostic tools, staging of a disease and responsiveness to treatment. Representative …
Brain natriuretic peptide and preclinical chronic thromboembolic pulmonary hypertension
We thank Dr. Miniati for his comments [1] on our article regarding the role of brain natriuretic
peptide (BNP) in the early diagnosis of chronic thromboembolic pulmonary hypertension …
peptide (BNP) in the early diagnosis of chronic thromboembolic pulmonary hypertension …
Клиническое значение определения натрийуретических пептидов при прекапиллярной легочной гипертензии и перспективные методы ее лечения
АА Клименко, НА Демидова, НА Шостак… - Российские …, 2012 - elibrary.ru
Цель обзора. Изучить данные современной медицинской литературы о роли
мозгового натрийуретического пептида в диагностике прекапиллярной легочной …
мозгового натрийуретического пептида в диагностике прекапиллярной легочной …
Factores de riesgo de la hipertensión pulmonar tromboembólica crónica
D Jiménez, J Gaudó, A Sueiro - Archivos de Bronconeumología, 2009 - Elsevier
Aunque la preocupación de la comunidad científica por la hipertensión pulmonar
tromboembólica crónica (HPTEC) es cada vez mayor, la patogenia de esta enfermedad no …
tromboembólica crónica (HPTEC) es cada vez mayor, la patogenia de esta enfermedad no …
Brain natriuretic peptide in chronic thromboembolic pulmonary hypertension
M Miniati - Internal and Emergency Medicine, 2009 - Springer
Chronic thromboembolic pulmonary hypertension (CTPH) is a severe and potentially fatal
complication of pulmonary embolism (PE). Reportedly, the cumulative incidence of CTPH is …
complication of pulmonary embolism (PE). Reportedly, the cumulative incidence of CTPH is …
Biomarkers for cardiovascular diseases: their clinical significances and future directions
藤井聡， フジイサトシ， 伊藤敦巳… - Annals of …, 2016 - asahikawa-med.repo.nii.ac.jp
Biomarkers are used for evaluation of the pathophysiological state, risk stratification,
diagnostic tools, staging of a disease and responsiveness to treatment. Representative …
diagnostic tools, staging of a disease and responsiveness to treatment. Representative …
Plazma B-Natriretik Peptid (BNP) Dzeyi Kronik Akciğer Hastalıklarında Pulmoner Hipertansiyon iin Gsterge Olabilir mi?
G Okumuş, E Kıyan, AK Bilge, Z Bingl… - … Journal/Turk Toraks …, 2011 - search.ebscohost.com
Amaç: BNP kardiyak volüm ve basınç artışına cevap olarak ventriküllerden salınan bir
nöropeptiddir. Bu nedenle konjestif kalp yetmezliğinde, hatta asemptomatik sol ventrikül …
nöropeptiddir. Bu nedenle konjestif kalp yetmezliğinde, hatta asemptomatik sol ventrikül …
Plazma B-Natriüretik Peptid (BNP) Düzeyi Kronik Akciger Hastaliklarinda Pulmoner Hipertansiyon için Gösterge Olabilir mi?/Can Brain Natriuretic Peptide (BNP) be a …
G Okumus, E Kiyan, AK Bilge, Z Bingöl… - Thoracic Research …, 2011 - search.proquest.com
GEREÇ ve YÖNTEM Çalismaya Istanbul Tip Fakültesi Gögüs Hastaliklari kliniginde takip
edilen 104 stabil kronik akciger hastaligi olgusu dahil edildi. Pulmoner hipertansiyon …
edilen 104 stabil kronik akciger hastaligi olgusu dahil edildi. Pulmoner hipertansiyon …
[PDF][PDF] Διοικητικο Συμβουλιο
Γ Γραμματέας, Ε Γραμματέας - mednet.gr
Διοικητικο Συμβουλιο ΕΠΙΜΕΛΕΙΑ ΕΚΔΟΣΗΣ ΓΝ Ζωγράφος, Β. Ντελής ΑΘΗΝΑ 2013 ΤΟΜΟΣ
25 ΤΕΥΧΟΣ 4 ΟΞΕΙΑ ΠΑΓΚΡΕΑΤΙΤΙΣ Page 2 Διοικητικο Συμβουλιο Πρόεδρος Á. Óêïõôåëçσ …
25 ΤΕΥΧΟΣ 4 ΟΞΕΙΑ ΠΑΓΚΡΕΑΤΙΤΙΣ Page 2 Διοικητικο Συμβουλιο Πρόεδρος Á. Óêïõôåëçσ …
[PDF][PDF] Plazma B-natriüretik peptid (BNP) düzeyi kronik akciğer hastalıklarında pulmoner hipertansiyon için gösterge olabilir mi?
G Okumuş, E Kıyan, AK Bilge, Z Bingöl… - Turkish Thoracic …, 2011 - thoracrespract.org
Amaç: BNP kardiyak volüm ve basınç artışına cevap olarak ventriküllerden salınan bir
nöropeptiddir. Bu nedenle konjestif kalp yetmezliğinde, hatta asemptomatik sol ventrikül …
nöropeptiddir. Bu nedenle konjestif kalp yetmezliğinde, hatta asemptomatik sol ventrikül …